by Canadian Medical Association Journal Transmission electron micrograph of SARS-CoV-2 virus particles (colored yellow) within the endosomes of a heavily infected nasal olfactory epithelial cell. Credit: NIAID A booster (third) dose of a SARS-CoV-2 vaccine was associated with a 90% reduction in death in people with multiple health conditions compared to 2 doses, according to a new...
Credit: Unsplash/CC0 Public Domain U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax. The Food and Drug Administration said the new booster option is for people 18 and older who can’t get the updated omicron-targeting Pfizer or Moderna boosters for medical or accessibility reasons—or who otherwise would not receive...
by Pasteur Institute 3D visualization of mutations in the spike protein of the Omicron variant. Left: overhead view. Right: lateral view. Mutations are indicated in red. They occur all over the spike protein but particularly in the receptor binding domain (RBD) and in the region known as the N-terminal domain (NTD). Credit: Institut Pasteur –...
By Matthew Herper and Helen Branswell Oct. 15, 2021 PATRICK T. FALLON/AFP VIA GETTY IMAGES For archived live coverage of the hearing of the FDA’s advisory panel, click here. A Food and Drug Administration advisory panel voted Friday that booster shots should be made available to people who have received the Johnson & Johnson Covid-19 vaccine. Unlike the...
Credit: Pixabay/CC0 Public Domain Most side effects after a third dose of a COVID vaccine are mild or moderate and occur at about as often as after shot two, a US study showed Tuesday in a finding that was expected but nonetheless reassuring. The report by the Centers for Disease Control and Prevention (CDC) came...
The panel opposed, however, clearing a third shot widely for use in people older than 16 years of age.Published Sept. 17, 2021 • Shoshana DubnowAssociate Editor Ned Pagliarulo Lead Editor Jens Schlueter via Getty Images A Food and Drug Administration advisory panel on Friday unanimously supported giving a third shot of Pfizer and BioNTech’s coronavirus vaccine...
